AAPG CIK: 2023311

Ascentage Pharma Group International

  • China
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions CNY
FY21:
1.89
FY22:
1.64
FY23:
1.34
FY24:
1.47
FY25:
2.94
(positive)
Change from FY21 to FY25
billions CNY
FY21:
1.05
FY22:
1.19
FY23:
1.16
FY24:
1.14
FY25:
1.02
Total assets
Change from FY21 to FY25
billions CNY
FY21:
2.94
FY22:
2.83
FY23:
2.50
FY24:
2.62
FY25:
3.96

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions CNY
FY21:
0.36
FY22:
0.88
FY23:
0.93
FY24:
1.17
FY25:
1.64
(negative)
Change from FY21 to FY25
billions CNY
FY21:
1.34
FY22:
1.54
FY23:
1.50
FY24:
1.18
FY25:
0.99
(positive)
Change from FY21 to FY25
billions CNY
FY21:
1.23
FY22:
0.41
FY23:
0.07
FY24:
0.27
FY25:
1.33
Total liabilities & equity
Change from FY21 to FY25
billions CNY
FY21:
2.94
FY22:
2.83
FY23:
2.50
FY24:
2.62
FY25:
3.96

All amounts in billions CNY Data source:Twelve Data